These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23971691)

  • 21. The role of angiotensin II in cancer metastasis: Potential of renin-angiotensin system blockade as a treatment for cancer metastasis.
    Ishikane S; Takahashi-Yanaga F
    Biochem Pharmacol; 2018 May; 151():96-103. PubMed ID: 29534876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of the renin-angiotensin system in gynecologic cancers.
    Ino K; Shibata K; Yamamoto E; Kajiyama H; Nawa A; Mabuchi Y; Yagi S; Minami S; Tanizaki Y; Kobayashi A; Kikkawa F
    Curr Cancer Drug Targets; 2011 May; 11(4):405-11. PubMed ID: 21395551
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Can the renin-angiotensin system protect against stroke? A focus on angiotensin II receptor blockers.
    Epstein BJ; Gums JG
    Pharmacotherapy; 2005 Apr; 25(4):531-9. PubMed ID: 15977915
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A clinical approach in regression of glomerulosclerosis.
    Stoian M; Radulian G; Chiţac D; Simion E; Stoica V
    Rom J Intern Med; 2007; 45(2):215-8. PubMed ID: 18333378
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibiting the renin-angiotensin system: why and in which patients.
    Berra K; Miller NH
    J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined treatment with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: a review of the current evidence.
    Tsouli SG; Liberopoulos EN; Kiortsis DN; Mikhailidis DP; Elisaf MS
    J Cardiovasc Pharmacol Ther; 2006 Mar; 11(1):1-15. PubMed ID: 16703216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alzheimer disease--contribution of renin-angiotensin system to Alzheimer disease progression].
    Ohrui T
    Nihon Rinsho; 2012 Sep; 70(9):1599-603. PubMed ID: 23012810
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of the renin-angiotensin system in thoracic aortic aneurysms: clinical implications.
    Moltzer E; Essers J; van Esch JH; Roos-Hesselink JW; Danser AH
    Pharmacol Ther; 2011 Jul; 131(1):50-60. PubMed ID: 21504760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of the renin-angiotensin system on abdominal aortic aneurysms.
    Malekzadeh S; Fraga-Silva RA; Trachet B; Montecucco F; Mach F; Stergiopulos N
    Eur J Clin Invest; 2013 Dec; 43(12):1328-38. PubMed ID: 24138426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Update on new aspects of the renin-angiotensin system in liver disease: clinical implications and new therapeutic options.
    Grace JA; Herath CB; Mak KY; Burrell LM; Angus PW
    Clin Sci (Lond); 2012 Aug; 123(4):225-39. PubMed ID: 22548407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Renin-angiotensin system inhibitor and statins combination therapeutics - what have we learnt?
    Koh KK; Sakuma I; Hayashi T; Kim SH; Chung WJ
    Expert Opin Pharmacother; 2015 May; 16(7):949-53. PubMed ID: 25747324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
    Verdecchia P; Gentile G; Angeli F; Reboldi G
    Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of the central renin-angiotensin system in Parkinson's disease.
    Mertens B; Vanderheyden P; Michotte Y; Sarre S
    J Renin Angiotensin Aldosterone Syst; 2010 Mar; 11(1):49-56. PubMed ID: 19861346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A; Divchev D; Luchtefeld M; Schieffer B
    Minerva Cardioangiol; 2009 Dec; 57(6):773-85. PubMed ID: 19942847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of cardiovascular damage: the role of renin-angiotensin system blockade.
    Probstfield JL; O'Brien KD
    Am J Cardiol; 2010 Jan; 105(1 Suppl):10A-20A. PubMed ID: 20102969
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On target to dual block RAS?
    Papadopoulos DP; Papademetriou V; Makris TK
    Angiology; 2009 Dec-2010 Jan; 60(6):739-49. PubMed ID: 19144653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of the renin-angiotensin system and target organ protection.
    Iwanami J; Mogi M; Iwai M; Horiuchi M
    Hypertens Res; 2009 Apr; 32(4):229-37. PubMed ID: 19262496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rationale for combining blockers of the renin-angiotensin system.
    Azizi M; Wuerzner G
    Semin Nephrol; 2007 Sep; 27(5):544-54. PubMed ID: 17868792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S; Srinivasan L; Verma M; Adigopula S; Jalandhara N; Hathiwala S; Smith E
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.